Coherus Biosciences Inc  

(Public, NASDAQ:CHRS)   Watch this stock  
Find more results for CHRS
13.15
+0.11 (0.84%)
Dec 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.38 - 13.43
52 week 12.27 - 16.25
Open 13.31
Vol / Avg. 203,194.00/273,970.00
Mkt cap 435.67M
P/E     -
Div/yield     -
EPS -2.69
Shares 33.26M
Beta     -
Inst. own 29%
Jan 12, 2015
Coherus Biosciences Inc at JPMorgan Healthcare Conference - 12:30PM EST - Add to calendar
Dec 15, 2014
Q3 2014 Coherus Biosciences Inc Earnings Call
Dec 15, 2014
Q3 2014 Coherus Biosciences Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -504.93% -1949.65%
Operating margin -361.29% -1308.36%
EBITD margin - -1293.67%
Return on average assets -104.83% -145.00%
Return on average equity - -
Employees 46 -
CDP Score - -

Address

201 Redwood Shores Pkwy Ste 200
REDWOOD CITY, CA 94065-1181
United States - Map
+1-650-6493530 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Coherus BioSciences Inc. (Coherus) is a late-stage clinical biologics platform Company. The Company is focused on delivering biosimilar therapeutics. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The Company has worked on approximately 100 molecules, developed and manufactured around 14 products and launched approximately 30 products across the world. Coherus´┐Ż is in partnerships include global pharmaceutical companies in Europe, Asia and Latin America.

Officers and directors

Dennis M. Lanfear Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Jean-Frederic Viret Ph.D. Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Michael A. Nazak Senior Vice President - Finance & Administration
Age: 56
Bio & Compensation  - Reuters
Peter K Watler Chief Technology Officer
Age: 52
Bio & Compensation  - Reuters
Alan C Herman Ph.D. Chief Scientific Officer
Age: 66
Bio & Compensation  - Reuters
Barbara K Finck M.D. Chief Medical Officer
Bio & Compensation  - Reuters
Christos Richards Director
Age: 57
Bio & Compensation  - Reuters
August J Troendle M.D. Director
Age: 58
Bio & Compensation  - Reuters
James I. Healy M.D., Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters
V. Bryan Lawlis Jr., Ph.D. Independent Director
Age: 62
Bio & Compensation  - Reuters